Follow

"Is curing patients a sustainable business model?...While the proposition offers tremendous value for patients and society, it would represent a challenge for genome medicine developers looking for sustained cash flows." - New York:Equity Research, Goldman Sachs, 2018. The Genome Revolution: Sizing the Genome Medicine Opportunity. Salveen Richter, etc al.

Found in Global Civil War: Capitalism Post-Pandemic. William I Robinson. PM Press. 2022.

Context was withholding cures. :-(

Is it too much of a stretch to believe capitalism will lead companies to create new illnesses, they can then cure for profit?

COVID-19 is considered likely man-made due to it's gain of function properties, but unlikely to be intentionally released. However, it's effects will likely be studied for potential future profit possibilities.

Show thread
Sign in to participate in the conversation
Librem Social

Librem Social is an opt-in public network. Messages are shared under Creative Commons BY-SA 4.0 license terms. Policy.

Stay safe. Please abide by our code of conduct.

(Source code)

image/svg+xml Librem Chat image/svg+xml